REFERENCE
sanofi-aventis.Sanofi-Aventis Statement Regarding U.S. FDA Joint Advisory Committee Recommendation for Ketek(R) (telithromycin). Media Release: 15 Dec 2006. Available from: URL: http://www.sanofi-aventis.com
Rights and permissions
About this article
Cite this article
A US FDA Joint Advisory Committee has recommended restricting the use of Ketek [telithromycin] to community acquired pneumonia. React. Wkly. 1133, 2 (2007). https://doi.org/10.2165/00128415-200711330-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200711330-00004